The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Positron Emission Tomography As an Imaging Biomarker
Abstract
Positron emission tomography (PET) allows noninvasive, quantitative studies of various biologic processes in the tumor tissue. By using PET, investigators can study the pharmacokinetics of anticancer drugs, identify various therapeutic targets and monitor the inhibition of these targets during therapy. Furthermore, PET provides various markers to assess tumor response early in the course of therapy. A significant number of studies have now shown that changes in tumor glucose utilization during the first weeks of chemotherapy are significantly correlated with patient outcome. These data suggest that PET may be used as a sensitive test to assess the activity of new cytotoxic agents in phase II studies. Furthermore, early identification of nonresponding tumors provides the opportunity to adjust treatment regimens according to the individual chemosensitivity of the tumor tissue. However, further prospective and randomized validation of PET is still required before PET controlled chemotherapy can be used in clinical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework
(2001) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2001.113989 · Cited by 6,762
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors
Demetri, G. D., von Mehren, M., Blanke, C. D., Van den Abbeele, A. D., Eisenberg, B., Roberts, P. J., Heinrich, M. C., Tuveson, D. A., Singer, S., Janicek, M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020461 · Cited by 4,389
Blume-Jensen, P., & Hunter, T. (2001) · Nature · doi:10.1038/35077225 · Cited by 3,738
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Young, H., Baum, R., Cremerius, U., Herholz, K., Hoekstra, O., Lammertsma, A. A., Pruim, J., & Price, P. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00229-4 · Cited by 1,720
A combined PET/CT scanner for clinical oncology.
Beyer, T., Townsend, D. W., Brun, T., Kinahan, P. E., Charron, M., Roddy, R., Jerin, J., Young, J., Byars, L. G., & Nutt, R. (2000) · PubMed · Cited by 1,659
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., & Smith, J. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.r000003200 · Cited by 1,356
Positron emission tomography provides molecular imaging of biological processes
Phelps, M. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.16.9226 · Cited by 1,229
Imaging proliferation in vivo with [F-18]FLT and positron emission tomography
Shields, A. F., Grierson, J. R., Dohmen, B. M., Machulla, H.-J., Stayanoff, J. C., Lawhorn-Crews, J. M., Obradovich, J. E., Muzik, O., & Mangner, T. J. (1998) · Nature Medicine · doi:10.1038/3337 · Cited by 1,204
Lawlor, M. A., & Alessi, D. R. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.16.2903 · Cited by 1,071
Function and interactions of integrins
van der Flier, A., & Sonnenberg, A. (2001) · Cell and Tissue Research · doi:10.1007/s004410100417 · Cited by 1,039
Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Hutchings, M., Loft, A., Hansen, M., Pedersen, L. M., Buhl, T., Jurlander, J., Buus, S., Keiding, S., D'Amore, F., Boesen, A.-M., et al. (2006) · Blood · doi:10.1182/blood-2005-06-2252 · Cited by 726
Weber, W. A., Ott, K., Becker, K., Dittler, H.-J., Helmberger, H., Avril, N. E., Meisetschläger, G., Busch, R., Siewert, J.-R., Schwaiger, M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.12.3058 · Cited by 701
Self-citationRole of Akt/protein kinase B in metabolism
Whiteman, E. L., Cho, H., & Birnbaum, M. J. (2002) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(02)00662-8 · Cited by 676
Kwekkeboom, D. J., Teunissen, J. J., Bakker, W. H., Kooij, P. P., de Herder, W. W., Feelders, R. A., van Eijck, C. H., Esser, J.-P., Kam, B. L., & Krenning, E. P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.066 · Cited by 657
Eliceiri, B. P., & Cheresh, D. A. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6869 · Cited by 649
Application of annihilation coincidence detection to transaxial reconstruction tomography.
Phelps, M. E., Hoffman, E. J., Mullani, N. A., & Ter‐Pogossian, M. M. (1975) · PubMed · Cited by 618
Haubner, R., Wester, H. J., Weber, W., Mang, C., Ziegler, S. I., Goodman, S. L., Senekowitsch–Schmidtke, R., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 563
Self-citationRasey, J. S., Koh, W.-J., Evans, M. L., Peterson, L. M., Lewellen, T. K., Graham, M. M., & Krohn, K. A. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(96)00325-2 · Cited by 562
Radiolabeled amino acids: basic aspects and clinical applications in oncology.
Jager, P. L., Vaalburg, W., Pruim, J., de Vries, E. G. E., Langen, K., & Piers, D. (2001) · PubMed · Cited by 558
A Systems Model of Signaling Identifies a Molecular Basis Set for Cytokine-Induced Apoptosis
Janes, K. A., Albeck, J. G., Gaudet, S., Sorger, P. K., Lauffenburger, D. A., & Yaffe, M. B. (2005) · Science · doi:10.1126/science.1116598 · Cited by 531
Stroobants, S., Goeminne, J., Seegers, M., Dimitrijevic, S., Dupont, P., Nuyts, J., Martens, M., van den Borne, B., Cole, P., Sciot, R., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00073-x · Cited by 526
Haioun, C., Itti, E., Rahmouni, A., Brice, P., Rain, J.-D., Belhadj, K., Gaulard, P., Garderet, L., Lepage, E., Reyes, F., et al. (2005) · Blood · doi:10.1182/blood-2005-01-0272 · Cited by 494
Weber, W. A., Petersen, V., Schmidt, B., Tyndale-Hines, L., Link, T., Peschel, C., & Schwaiger, M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.004 · Cited by 493
Self-citationHaubner, R., Weber, W. A., Beer, A. J., Vabuliene, E., Reim, D., Sarbia, M., Becker, K.-F., Goebel, M., Hein, R., Wester, H.-J., et al. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020070 · Cited by 489
Self-citationSynthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging.
Wester, H. J., Herz, M., Weber, W., et al. (1999) · PubMed · Cited by 466
Self-citationImaging of hypoxia in human tumors with [F-18]fluoromisonidazole
Koh, W.-J., Rasey, J. S., Evans, M. L., Grierson, J. R., Lewellen, T. K., Graham, M. M., Krohn, K. A., & Griffin, T. W. (1992) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(92)91001-4 · Cited by 463
Wieder, H. A., Brücher, B. L. D. M., Zimmermann, F., Becker, K., Lordick, F., Beer, A., Schwaiger, M., Fink, U., Siewert, J. R., Stein, H. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.122 · Cited by 454
Self-citationStabile, L. P., Davis, A. L. G., Gubish, C. T., Hopkins, T. M., Luketich, J. D., Christie, N. A., Finkelstein, S. D., & Siegfried, J. M. (2002) · PubMed · Cited by 453
Haubner, R., Finsinger, D., & Kessler, H. (1997) · Angewandte Chemie International Edition in English · doi:10.1002/anie.199713741 · Cited by 430
Chao, K. S. C., Bosch, W. R., Mutic, S., Lewis, J. S., Dehdashti, F., Mintun, M. A., Dempsey, J. F., Perez, C. A., Purdy, J. A., & Welch, M. J. (2001) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(00)01433-4 · Cited by 429
Breast cancer: PET imaging of estrogen receptors.
Mintun, M. A., Welch, M. J., Siegel, B. A., Mathias, C. J., Brodack, J. W., McGuire, A. H., & Katzenellenbogen, J. A. (1988) · Radiology · doi:10.1148/radiology.169.1.3262228 · Cited by 416
Phase II and Tumor Pharmacodynamic Study of Gefitinib in Patients with Advanced Breast Cancer
Baselga, J., Albanell, J., Ruiz, A., Lluch, A., Gascón, P., Guillém, V., González, S., Sauleda, S., Marimón, I., Tabernero, J. M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.326 · Cited by 411
Metabolic Flare: Indicator of Hormone Responsiveness in Advanced Breast Cancer
Mortimer, J. E., Dehdashti, F., Siegel, B. A., Trinkaus, K., Katzenellenbogen, J. A., & Welch, M. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.11.2797 · Cited by 410
Mikhaeel, N. G., Hutchings, M., Fields, P. A., O'Doherty, M. J., & Timothy, A. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi272 · Cited by 401
Waldherr, C., Pless, M., Maecke, H. R., Haldemann, A., & Mueller-Brand, J. (2001) · Annals of Oncology · doi:10.1023/a:1011160913619 · Cited by 396
Hypoxia and Glucose Metabolism in Malignant Tumors
Rajendran, J. G., Mankoff, D. A., O’Sullivan, F., Peterson, L. M., Schwartz, D. L., Conrad, E. U., Spence, A. M., Muzi, M., Farwell, D. G., & Krohn, K. A. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0688-3 · Cited by 390
Reproducibility of metabolic measurements in malignant tumors using FDG PET.
Weber, W., Ziegler, S. I., Thödtmann, R., Hanauske, A.-R., & Schwaiger, M. (1999) · PubMed · Cited by 388
Self-citationImaging the expression of transfected genes in vivo.
Tjuvajev, J. G., Stockhammer, G., Desai, R., Uehara, H., Watanabe, K. A., Gänsbacher, B., & Blasberg, R. G. (1995) · PubMed · Cited by 386
Grosu, A. L., Weber, W. A., Franz, M., Stärk, S., Piert, M., Thamm, R., Gumprecht, H., Schwaiger, M., Molls, M., & Nieder, C. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.056 · Cited by 373
Self-citationRadiolabeled alpha(v)beta3 integrin antagonists: a new class of tracers for tumor targeting.
Haubner, R., Wester, H., Reuning, U., Senekowitsch–Schmidtke, R., Diefenbach, B., Kessler, H., Stöcklin, G., & Schwaiger, M. (1999) · PubMed · Cited by 356
Tjuvajev, J. G., Finn, R., Watanabe, K. A., Joshi, R., Oku, T., Kennedy, J. D., Beattie, B. J., Koutcher, J. A., Larson, S. M., & Blasberg, R. G. (1996) · PubMed · Cited by 332
Tumor targeting with radiolabeled alpha(v)beta(3) integrin binding peptides in a nude mouse model.
Janssen, M. L., Oyen, W. J. G., Dijkgraaf, I., Massuger, L. F. A. G., Frielink, C., Edwards, D. S., Rajopadhye, M., Boonstra, H., Corstens, F. H. M., & Boerman, O. C. (2002) · PubMed · Cited by 331
Dehdashti, F., Grigsby, P. W., Mintun, M. A., Lewis, J. S., Siegel, B. A., & Welch, M. J. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04477-2 · Cited by 326
Ott, K., Fink, U., Becker, K., Stahl, A., Dittler, H.-J., Busch, R., Stein, H., Lordick, F., Link, T., Schwaiger, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.574 · Cited by 318
Self-citationAntoch, G., Kanja, J., Bauer, S., Kuehl, H., Renzing-Koehler, K., Schuette, J., Bockisch, A., Debatin, J. F., & Freudenberg, L. S. (2004) · PubMed · Cited by 312
Findlay, M., Young, H., Cunningham, D., Iveson, A., Cronin, B., Hickish, T., Pratt, B., Husband, J., Flower, M., & Ott, R. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.3.700 · Cited by 310
Vesselle, H. J., Grierson, J. R., Muzi, M., Pugsley, J. M., Schmidt, R. A., Rabinowitz, P., Peterson, L. M., Vallières, E., & Wood, D. E. (2002) · PubMed · Cited by 300
Larson, S. M., Morris, M. J., Guenther, I., Beattie, B., Humm, J. L., Akhurst, T., Finn, R. D., Erdi, Y. E., Pentlow, K. S., Dyke, J., et al. (2004) · PubMed · Cited by 298
Dehdashti, F., Flanagan, F. L., Mortimer, J. E., Katzenellenbogen, J. A., Welch, M. J., & Siegel, B. A. (1999) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s002590050359 · Cited by 290
Belhocine, T., Steinmetz, N. D., Hustinx, R., Bartsch, P., Jérusalem, G., Seidel, L., Rigo, P., & Green, A. M. (2002) · PubMed · Cited by 289
Koh, W.-J., Bergman, K. S., Rasey, J. S., Peterson, L. M., Evans, M. L., Graham, M. M., Grierson, J. R., Lindsley, K. L., Lewellen, T. K., Krohn, K. A., et al. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00170-4 · Cited by 288
Avril, N., Sassen, S., Schmalfeldt, B., Naehrig, J., Rutke, S., Weber, W. A., Werner, M., Graeff, H., Schwaiger, M., & Kuhn, W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.965 · Cited by 283
Self-citationGayed, I. W., Vu, T., Iyer, R. B., Johnson, M. M., Macapinlac, H. A., Swanston, N. M., & Podoloff, D. A. (2004) · PubMed · Cited by 282
Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.
Zhang, X., Xiong, Z., Wu, Y., Cai, W., Tseng, J. R., Gambhir, S. S., & Chen, X. S. (2006) · PubMed · Cited by 282
Barthel, H., Cleij, M. C., Collingridge, D. R., Hutchinson, O. C., Osman, S., He, Q., Luthra, S. K., Brady, F., Price, P., & Aboagye, E. O. (2003) · PubMed · Cited by 271
Brain tumour imaging with PET: a comparison between [ 18 F]fluorodopa and [ 11 C]methionine
Becherer, A., Karanikas, G., Szab�, M., Zettinig, G., Asenbaum, S., Marosi, C., Henk, C., Wunderbaldinger, P., Czech, T., Wadsak, W., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1259-1 · Cited by 266
Minn, H., Zasadny, K. R., Quint, L. E., & Wahl, R. L. (1995) · Radiology · doi:10.1148/radiology.196.1.7784562 · Cited by 260
Jayson, G. C., Zweit, J., Jackson, A., Mulatero, C., Julyan, P., Ranson, M., Broughton, L., Wagstaff, J., Hakannson, L., Groenewegen, G., et al. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1484 · Cited by 258
Beer, A. J., Haubner, R., Goebel, M., Luderschmidt, S., Spilker, M. E., Wester, H., Weber, W., & Schwaiger, M. (2005) · PubMed · Cited by 258
Self-citationJansson, T., Westlin, J. E., Ahlström, H., Lilja, A., Långström, B., & Bergh, J. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.6.1470 · Cited by 257
Van den Abbeele, A. D., & Badawi, R. D. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)80604-9 · Cited by 257
Chen, X. S., Hou, Y., Tohme, M. S., Park, R. J.-H., Khankaldyyan, V., Gonzales-Gomez, I., Bading, J. R., Laug, W. E., & Conti, P. S. (2004) · PubMed · Cited by 254
Rajendran, J. G., Wilson, D. C., Conrad, E. U., Peterson, L. M., Bruckner, J. D., Rasey, J. S., Chin, L. K., Hofstrand, P. D., Grierson, J. R., Eary, J. F., et al. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1096-7 · Cited by 252
Brun, E., Kjellén, E., Tennvall, J., Ohlsson, T., Sandell, A., Perfekt, R., Perfekt, R., Wennerberg, J., & Strand, S. E. (2002) · Head & Neck · doi:10.1002/hed.10037 · Cited by 251
Hoekstra, C. J., Stroobants, S. G., Smit, E. F., Vansteenkiste, J., van Tinteren, H., Postmus, P. E., Golding, R. P., Biesma, B., Schramel, F. J. H. M., van Zandwijk, N., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.1189 · Cited by 247
Grosu, A., Weber, W., Riedel, E., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.01.045 · Cited by 242
Self-citation(68)Ga-labeled peptides in tumor imaging.
Maëcke, H. R., Hofmann, M., & Haberkorn, U. (2005) · PubMed · Cited by 242
Mamede, M., Higashi, T., Kitaichi, M., Ishizu, K., Ishimori, T., Nakamoto, Y., Yanagihara, K., Li, M., Tanaka, F., Wada, H., et al. (2005) · Neoplasia · doi:10.1593/neo.04577 · Cited by 231
Hypoxia in human gliomas: demonstration by PET with fluorine-18-fluoromisonidazole.
Valk, P. E., Mathis, C. A., Prados, M. D., Gilbert, J. C., & Budinger, T. F. (1992) · PubMed · Cited by 224
Quantification of target gene expression by imaging reporter gene expression in living animals
Yu, Y., Annala, A. J., Barrio, J. R., Toyokuni, T., Satyamurthy, N., Namavari, M., Cherry, S. R., Phelps, M. E., Herschman, H. R., & Gambhir, S. S. (2000) · Nature Medicine · doi:10.1038/78704 · Cited by 223
Peñuelas, I., Mazzolini, G., Boán, J. F., Sangro, B., Martí-Climent, J., Ruiz, M., Ruiz, J., Satyamurthy, N., Qian, C., Barrio, J. R., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.024 · Cited by 220
Buck, A. K., Schirrmeister, H., Hetzel, M., Heide, M. V. D., Halter, G., Glatting, G., Mattfeldt, T., Liewald, F., Reske, S. N., & Neumaier, B. (2002) · PubMed · Cited by 213
Mankoff, D. A., Dunnwald, L. K., Gralow, J. R., Ellis, G. K., Schubert, E. K., Tseng, J. R., Lawton, T. J., Linden, H. M., & Livingston, R. B. (2003) · PubMed · Cited by 200
O’Donoghue, J. A., Zanzonico, P., Pugachev, A., Wen, B., Smith-Jones, P., Cai, S., Burnazi, E., Finn, R. D., Burgman, P., Ruan, S., et al. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.12.057 · Cited by 184
Herbst, R. S., Mullani, N. A., Davis, D. W., Hess, K. R., McConkey, D. J., Charnsangavej, C., O’Reilly, M. S., Kim, H.-W., Baker, C., Roach, J., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.05.102 · Cited by 180
Wagner, M., Seitz, U., Buck, A. K., Neumaier, B., Schultheiß, S., Bangerter, M., Bommer, M., Leithäuser, F., Wawra, E., Munzert, G. M., et al. (2003) · PubMed · Cited by 178
Evaluation of 18F-annexin V as a PET imaging agent in an animal model of apoptosis.
Yagle, K. J., Eary, J. F., Tait, J. F., Grierson, J. R., Link, J. M., Lewellen, B., Gibson, D. F., & Krohn, K. A. (2005) · PubMed · Cited by 160
Aloj, L., Caracò, C., Jagoda, E. M., Eckelman, W. C., & Neumann, R. D. (1999) · PubMed · Cited by 155
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy
van Hagen, P. M., Breeman, W. A. P., Bernard, H. F., Schaar, M., Mooij, C. M., Srinivasan, A., Schmidt, M. A., Krenning, E. P., & de Jong, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000820)90:4<186::aid-ijc2>3.0.co;2-p · Cited by 142
Higashi, K., Clavo, A. C., & Wahl, R. L. (1993) · PubMed · Cited by 141
Brambilla, M., Secco, C., Dominietto, M. D., Matheoud, R., Sacchetti, G., & Inglese, E. (2005) · PubMed · Cited by 131
Schottelius, M., Poethko, T., Herz, M., Reubi, J., Kessler, H., Schwaiger, M., & Wester, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0359 · Cited by 108
Waldherr, C., Mellinghoff, I. K., Tran, C., Halpern, B. S., Rozengurt, N., Safaei, A., Weber, W., Stout, D., Satyamurthy, N., Barrio, J. R., et al. (2005) · PubMed · Cited by 104
Self-citationSUGIYAMA, M., Sakahara, H., Sato, K., Harada, N., Fukumoto, D., Kakiuchi, T., Hirano, T., Kohno, E., & Tsukada, H. (2004) · PubMed · Cited by 96
Glucose Uptake by Gliomas After Treatment
Rozental, J. M. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520480044018 · Cited by 92
Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
Weber, W., Bartenstein, P., Groß, M. W., Kinzel, D., Daschner, H., Feldmann, H. J., Reidel, G., Ziegler, S. I., Lumenta, C. B., Molls, M., et al. (1997) · PubMed · Cited by 89
Self-citationPreclinical evaluation of fluorine-18-labeled androgen receptor ligands in baboons.
Bonasera, T. A., O’Neil, J. P., Xu, M. G., Dobkin, J., Cutler, P. D., Lich, L. L., Choe, Y. S., Katzenellenbogen, J. A., & Welch, M. J. (1996) · PubMed · Cited by 85
An In vivo Tumor Model Exploiting Metabolic Response as a Biomarker for Targeted Drug Development
Cullinane, C. M., Dorow, D. S., Kansara, M., Conus, N. M., Binns, D., Hicks, R. J., Ashman, L. K., McArthur, G. A., & Thomas, D. M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2285 · Cited by 79
Matsumoto, K., Kitamura, K., Mizuta, T., Tanaka, K., Yamamoto, S., Sakamoto, S., Nakamoto, Y., Amano, M., Murase, K., & Senda, M. (2006) · PubMed · Cited by 78
Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
Oyama, N., Ponde, D. E., Dence, C. S., Kim, J., Tai, Y., & Welch, M. J. (2004) · PubMed · Cited by 76
Yang, Y.-J., Ryu, J., Kim, S.-Y., Oh, S. J., Im, K. C., Lee, H., Lee, S.-W., Cho, K. J., Cheon, G. J., & Moon, D. H. (2006) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-0011-4 · Cited by 71
Gene therapy imaging in patients for oncological applications
Peñuelas, I., Haberkorn, U., Yaghoubi, S. S., & Gambhir, S. S. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1928-3 · Cited by 68
Collingridge, D. R., Glaser, M., Osman, S., Barthel, H., Hutchinson, O. C., Luthra, S. K., Brady, F., Bouchier‐Hayes, L., Martin, S. J., Workman, P., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601262 · Cited by 67
Imaging vascular physiology to monitor cancer treatment
Laking, G. R., West, C., Buckley, D. L., Matthews, J. C., & Price, P. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.10.006 · Cited by 55
Hooft, L., van der Veldt, A. A. M., van Diest, P. J., Hoekstra, O. S., Berkhof, J. H., Teule, G. J. J., & Molthoff, C. F. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0779 · Cited by 52
A Physiologic Imaging Pilot Study of Breast Cancer Treated with AZD2171
Miller, K. D., Miller, M. A., Mehrotra, S., Agarwal, B., Mock, B. H., Zheng, Q., Badve, S., Hutchins, G. D., & Sledge, G. W. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0219 · Cited by 31
Hexokinase-II expression in untreated oral squamous cell carcinoma: Comparison with FDG PET imaging
Tian, M., Zhang, H., Higuchi, T., Oriuchi, N., Nakasone, Y., Takata, K., Nakajima, N., Mogi, K., & Endo, K. (2005) · Annals of Nuclear Medicine · doi:10.1007/bf02984629 · Cited by 27
Paans, A. M. J., Pruim, J., van Waarde, A., Willemsen, A. T. M., & Vaalburg, W. (1996) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(96)80666-5 · Cited by 12
Cited by
From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
Wahl, R. L., Jacene, H., Kasamon, Y., & Lodge, M. A. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.057307 · Cited by 3,777
New approaches and procedures for cancer treatment: Current perspectives
Debela, D. T., Muzazu, S. G., Heraro, K. D., Ndalama, M. T., Mesele, B. W., Haile, D. C., Kitui, S. K., & Manyazewal, T. (2021) · SAGE Open Medicine · doi:10.1177/20503121211034366 · Cited by 1,597
Molecular imaging in drug development
Willmann, J. K., van Bruggen, N., Dinkelborg, L. M., & Gambhir, S. S. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2290 · Cited by 1,171
Synthesis of 11C, 18F, 15O, and 13N Radiolabels for Positron Emission Tomography
Miller, P. W., Long, N. J., Vilar, R., & Gee, A. D. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200800222 · Cited by 894
Day, S. E., Kettunen, M. I., Gallagher, F. A., Hu, D.-E., Lerche, M., Wolber, J., Golman, K., Ardenkjaer-Larsen, J. H., & Brindle, K. M. (2007) · Nature Medicine · doi:10.1038/nm1650 · Cited by 883
Metadata
- Authors
- Weber, W. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-07-10
- Volume
- 24
- Issue
- 20
- Pages
- 3282-3292
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2150818243
- Cited by
- 312
- References
- 101
- FWCI
- 24.18
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.